BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1863 related articles for article (PubMed ID: 29144072)

  • 21. Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantation.
    Agis H; Mannhalter C; Sperr WR; Keil F; Kalhs P; Pirc-Danoewinata H; Krauth MT; Haas OA; Geissler K; Lechner K; Valent P
    Leuk Lymphoma; 2004 Jul; 45(7):1453-8. PubMed ID: 15359647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.
    Deeg HJ; Scott BL; Fang M; Shulman HM; Gyurkocza B; Myerson D; Pagel JM; Platzbecker U; Ramakrishnan A; Radich JP; Sandmaier BM; Sorror M; Stirewalt DL; Wilson WA; Storb R; Appelbaum FR; Gooley T
    Blood; 2012 Aug; 120(7):1398-408. PubMed ID: 22767498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytogenetic scenario of chronic myeloid leukemia.
    Mitelman F
    Leuk Lymphoma; 1993; 11 Suppl 1():11-5. PubMed ID: 8251885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.
    Mohamed AN; Pemberton P; Zonder J; Schiffer CA
    Clin Cancer Res; 2003 Apr; 9(4):1333-7. PubMed ID: 12684401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of AML without karyotype abnormalities including the Ph chromosome in a CML patient on second-generation TKI therapy].
    Sakai T; Konuma Y; Shimoyama S; Kohda K
    Rinsho Ketsueki; 2016; 57(11):2329-2333. PubMed ID: 27941281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes.
    Kelaidi C; Tzannou I; Baltadakis I; Batsis I; Mallouri D; Spyridonidis A; Gigantes S; Tsirigotis P; Apostolidis I; Athanasiadou A; Manola K; Anagnostopoulos A; Harhalakis N; Sakellari I; Karakasis D
    Bone Marrow Transplant; 2014 Aug; 49(8):1022-8. PubMed ID: 24797183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
    Rogers HJ; Vardiman JW; Anastasi J; Raca G; Savage NM; Cherry AM; Arber D; Moore E; Morrissette JJ; Bagg A; Liu YC; Mathew S; Orazi A; Lin P; Wang SA; Bueso-Ramos CE; Foucar K; Hasserjian RP; Tiu RV; Karafa M; Hsi ED
    Haematologica; 2014 May; 99(5):821-9. PubMed ID: 24463215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in karyotype between diagnosis and first relapse in acute myelogenous leukemia.
    Estey E; Keating MJ; Pierce S; Stass S
    Leukemia; 1995 Jun; 9(6):972-6. PubMed ID: 7596187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
    Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional cancer cytogenetics: a report on 1,143 diagnostic cases.
    Perkins D; Brennan S; Carstairs K; Bailey D; Pantalony D; Poon A; Fernandes B; Dubé I
    Cancer Genet Cytogenet; 1997 Jul; 96(1):64-80. PubMed ID: 9209473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
    Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
    Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Karyotype evolution of Ph positive chronic myelogenous leukemia patients relapsed in advanced phases of the disease after allogeneic bone marrow transplantation.
    Sessarego M; Frassoni F; Defferrari R; Bacigalupo A; Fugazza G; Mareni C; Bruzzone R; Dejana A; Ajmar F
    Cancer Genet Cytogenet; 1991 Nov; 57(1):69-78. PubMed ID: 1756487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ph+ acute myelogenous leukemia with t(7;11)(p15;p15) and clonal evolution in relapse after bone marrow transplantation.
    Miura I; Nishinari T; Hashimoto K; Nimura T; Takatsu H; Niitsu H; Hirokawa M; Kuwayama A; Nishimura S; Miura AB
    Acta Haematol; 1993; 90(3):148-50. PubMed ID: 8291375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ph-negative isolated myeloid sarcoma with NPM1 gene mutation in adolescent with Ph-positive chronic myeloid leukemia in remission after treatment with allogeneic bone marrow transplantation and imatinib mesylate.
    Skalska-Sadowska J; Januszkiewicz-Lewandowska D; Derwich K; Pieczonka A; Samborska M; Wachowiak J
    Pediatr Blood Cancer; 2015 Jun; 62(6):1070-1. PubMed ID: 25631405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia.
    Przepiorka D; Thomas ED
    Bone Marrow Transplant; 1988 Mar; 3(2):113-9. PubMed ID: 3048475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case Report of acute myeloid leukemia with "WT1, ATRX, CEBPA, CSMD1, IKZF1, and LRP1B mutation and translocation between chromosome 1 and 19" developing from Philadelphia-negative chronic myeloid leukemia after TKI therapy.
    Zhu H; Yang B; Liu J; Wu W; Ling Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18888. PubMed ID: 32011516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation.
    Schmidt-Hieber M; Blau IW; Richter G; Türkmen S; Bommer C; Thiel G; Neitzel H; Stroux A; Uharek L; Thiel E; Blau O
    Cancer Genet Cytogenet; 2010 Apr; 198(2):135-43. PubMed ID: 20362228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 94.